Artificial Intelligence

research deal two people shaking hands in lab

Merck opts in on Evaxian's preclinical vaccine candidate

Merck is licensing one of Evaxion’s AI platform-based vaccine candidates, offering the biotech up to $592 million for rights to the preclinical asset.

Gabrielle Masson Sep 25, 2025 7:00am

Heartflow's updated coronary plaque AI nets FDA clearance

Sep 24, 2025 12:00pm

Medtronic to double its London center for AI, robotic surgery

Sep 23, 2025 2:30pm

3D Rendering futuristic robot technology development artificial intelligence

Merck inks $349M biobucks deal to apply AI to tricky targets

Sep 23, 2025 7:00am

Flagship's Lila lands $235M to expand AI-powered research labs

Sep 15, 2025 2:25pm

IQVIA unveils AI suite for managing clinical trial finances

Sep 10, 2025 2:44pm